The Question Nobody Asks About Seasonal Supplementation

People who take Ashwagandha (Withania somnifera) for stress or sleep often continue the same product and dose throughout the year. Seasonal review can still be useful, especially when climate, hydration, appetite, sleep, work demands, or medication use changes. However, neither modern clinical trials nor the Ayurvedic Pharmacopoeia of India provides a universal rule that Ashwagandha must be increased, reduced, or stopped during summer.

Two distinct frameworks should be kept separate. Modern studies examine outcomes such as perceived stress, sleep quality, and cortisol concentrations. Ayurveda evaluates the season together with dosha, agni, bala, satmya, present symptoms, diet, and the properties of the medicine. Cortisol should not be equated with Pitta, and an Ayurvedic property such as ushna virya should not be translated into a specific hormonal effect.

Cortisol Has Daily and Seasonal Variation

Cortisol follows a strong circadian rhythm, ordinarily rising around awakening and declining toward the evening. Its measured concentration is affected by sampling time, sleep timing, waking time, light exposure, illness, medication, and the type of specimen used. A single morning or evening result therefore cannot describe the entire daily cortisol pattern.

In a 2008 longitudinal study, participants collected saliva at four times on one workday during each of 12 consecutive months. The daily pattern remained similar across the months, while overall cortisol concentrations were highest during February through April and lowest during July and August. This finding does not support the claim that longer summer days necessarily flatten the diurnal curve.

A 2014 analysis evaluated 27,569 serum cortisol results collected by one large laboratory over 13 years. Season, daylight-saving time, sunrise, and sampling time were examined together, with the timing of sunrise and blood collection emerging as important influences. These observations establish that seasonal context can affect cortisol measurement, but they do not provide a basis for a summer-specific Ashwagandha dose.

What Classical Ritucharya Says About Grishma

Charaka Samhita, Sutra Sthana 6, describes Grishma Ritu as the final season of Adana Kala, when the sun progressively draws moisture from the environment and human strength is relatively weak. The text recommends foods and drinks that are predominantly sweet, cooling, liquid, and unctuous, together with protection from excessive heat and exertion.

The classical seasonal sequence also requires an important correction: Vata undergoes sanchaya, or physiological accumulation, during Grishma and becomes aggravated during the rainy season. Pitta accumulates during the rainy season and is aggravated in Sharad Ritu, or autumn. Summer heat may intensify burning, thirst, irritability, rashes, or acidity in a susceptible person, but that individual response is not the same as calling Grishma the classical season of Pitta accumulation.

Charaka’s Grishma regimen advises limiting salty, sour, pungent, and very hot foods, alcohol, strenuous exercise, and excessive sun exposure. Cooling shelter, light clothing, adequate rest, and suitable liquid nourishment are emphasized. These measures address the dehydrating and strength-reducing qualities of the season; they are not a fixed herbal dosing formula.

Ashwagandha in the Ayurvedic Pharmacopoeia of India

The Ayurvedic Pharmacopoeia of India, Part I, Volume I, defines Ashwagandha as the dried mature root of Withania somnifera Dunal. It lists tikta and kashaya rasa, laghu guna, ushna virya, and madhura vipaka. Its recorded actions include rasayana, balya, vajikarana, and pacification of Vata and Kapha. The pharmacopoeial dose for the powdered root is 3–6 g, but that range is not interchangeable with the milligram dose of a concentrated commercial extract.

Ushna virya is therefore an authentic pharmacopoeial attribute rather than a modern theory about thermogenesis. It is relevant when a practitioner evaluates a person with burning sensations, marked thirst, loose stools, reflux, bleeding tendency, inflammatory symptoms, or intolerance to heating medicines. It does not establish that every person must discontinue Ashwagandha in hot weather.

Ayurvedic selection also depends on the current disorder and not only on constitutional type. A person described as Pitta-predominant may still have a Vata-dominant condition for which Ashwagandha is being considered, while a Vata-predominant person may develop symptoms that make an ushna medicine unsuitable. A seasonal decision should consequently consider prakriti, vikriti, digestion, strength, climate, formulation, accompanying medicines, and observed response.

What Human Trials Establish

In the frequently cited 2012 randomized, double-blind trial, 64 adults with chronic stress were enrolled and 61 completed the study. Participants assigned to Ashwagandha received 300 mg of a standardized full-spectrum root extract twice daily for 60 days. Serum cortisol declined by 27.9% from baseline in the Ashwagandha group, alongside improvements in several stress-assessment scores. This was a small, single-centre study of one particular extract and should not be treated as a universal dosing standard.

A 2023 systematic review included nine human studies lasting 30–112 days. The products varied substantially in plant part, extraction method, withanolide standardization, dose, treatment duration, and cortisol-sampling procedure. All seven studies measuring plasma or serum cortisol reported reductions, whereas the two studies measuring salivary cortisol produced inconsistent results. The review also noted that cortisol collection time and circadian variation were not handled uniformly.

The trials summarized in that review did not define separate summer and winter regimens. They also do not establish that Ashwagandha becomes more effective when summer stress is greater or that it “normalizes” every disturbed cortisol pattern. Clinical results apply most directly to the particular extracts, populations, durations, and outcome measures that were tested.

The Heating Question in Summer

Ashwagandha’s ushna virya makes tolerability an appropriate consideration during hot weather, particularly when a person develops burning discomfort, reflux, loose stools, disturbed sleep, or a new sense of overstimulation after beginning or increasing a product. These symptoms are not specific measures of cortisol and may also arise from dehydration, infection, diet, another supplement, medication, or an unrelated medical condition.

Conversely, a person who is benefiting from a stable root preparation without adverse effects does not have to stop solely because the calendar has reached Grishma. The more defensible approach is to review the indication, product identity, current symptoms, and risk factors rather than applying a constitution-based milligram table. Neither the pharmacopoeial monograph nor the clinical trials assign fixed doses such as 150–300 mg for Pitta and 300–600 mg for Vata.

A Safer Framework for Summer Use

A seasonal review should determine whether the original reason for taking Ashwagandha remains present, whether the same preparation is being used, and whether hot weather has introduced symptoms or medical circumstances that alter its suitability. Dose changes are safest when made with a qualified Ayurvedic practitioner or healthcare professional who can distinguish root powder from standardized extracts and assess concurrent medicines.

Point to Review Continuation May Be Reasonable Professional Review Is Appropriate
Product The same clearly labelled root preparation is being used consistently The brand, plant part, extract ratio, withanolide level, or formula has changed
Response The intended benefit remains stable without new adverse effects There is new nausea, diarrhoea, marked drowsiness, rash, reflux, agitation, or palpitations
Seasonal condition Hydration, appetite, sleep, and heat exposure remain well managed There is dehydration, heat illness, persistent insomnia, poor intake, or unusual weakness
Medical context No new medicine, illness, surgery, pregnancy, or breastfeeding applies There is thyroid, autoimmune, liver, endocrine, or medication-related concern

Root powder, concentrated root extract, and combined root-and-leaf extract are not dose-equivalent. A capsule containing 300 mg of a standardized extract cannot be converted directly into 300 mg of traditional root powder, and percentages of total withanolides do not make products clinically identical. The product used in a successful trial should not be generalized automatically to every supplement labelled “Ashwagandha.”

Food, Timing, and Seasonal Routine

Classical Grishma guidance supports a broader cooling and conserving routine: avoid excessive midday heat and strenuous exertion, maintain appropriate fluid intake, favour suitable sweet, liquid, and unctuous foods, and limit habitual excess of pungent, sour, salty, alcoholic, and very hot items. These measures may be more important than altering a supplement solely because of the season.

No universal clinical protocol establishes that Ashwagandha must be taken at 6:00–7:00 PM to follow the evening cortisol decline. Trial schedules have varied, and some products can cause drowsiness while others may be poorly tolerated near bedtime. Timing should follow the practitioner’s instructions, the product label, meal tolerance, and the individual’s response rather than an assumed cortisol rule.

Ayurvedic Alternatives Are Not Interchangeable

Shatavari, Brahmi, Shankhapushpi, Amalaki, and Ashwagandha are distinct Ayurvedic drugs with different botanical identities, properties, parts used, indications, and safety considerations. Labelling one of them “cooling” does not make it a direct substitute for Ashwagandha or establish that it will produce the same effects on stress, sleep, or cortisol.

Fixed combinations such as 300 mg Ashwagandha with 500 mg Shatavari, or the routine addition of a quarter-teaspoon of Amalaki, are not standard seasonal instructions in the Ashwagandha pharmacopoeial monograph. Combining herbs can be appropriate within an individualized prescription, but the selection and quantity should follow the person’s condition, digestive capacity, formulation, and other treatment rather than a generic internet protocol.

Limits of Seasonal Dosing

The available human trials are mostly small and short, and they use heterogeneous extracts. They support the possibility that certain Ashwagandha preparations can reduce perceived stress, modestly improve sleep, and lower measured cortisol in some adults. They do not establish year-round treatment, long-term safety, constitution-specific supplement doses, or a distinct summer response.

Short-term use for up to about three months is generally better characterized than prolonged use. Reported adverse effects include stomach upset, loose stools, nausea, vomiting, and drowsiness. Rare cases of liver injury have been associated with Ashwagandha products, and thyroid effects have also been reported. Long-term self-treatment should not be assumed safe simply because a product is traditional or plant-based.

Bottom Line

Ashwagandha does not require an automatic summer dose reduction, but its authentic ushna virya, the depleting character of Grishma, the person’s present symptoms, and the exact preparation all deserve consideration. Continue only a clearly identified product that remains beneficial and well tolerated, and do not substitute pharmacopoeial root-powder doses for concentrated-extract doses.

Avoid Ashwagandha during pregnancy and breastfeeding. Consult a qualified Ayurvedic practitioner or healthcare provider before use if you have thyroid, autoimmune, liver, endocrine, or hormone-sensitive disease; are preparing for surgery; or take sedatives, anticonvulsants, immunosuppressants, thyroid hormone, diabetes medicines, or blood-pressure medicines. Stop the product and obtain medical care for jaundice, dark urine, severe itching, persistent vomiting, abdominal pain, or unusual fatigue.

References

  1. Mdpi (mdpi.com)
  2. Seasonal variation in human salivary cortisol concentration (2008), PubMed
  3. The effects of season, daylight saving and time of sunrise on serum cortisol in a large population (2014), PubMed
  4. Charaka Samhita — Tasyashiteeya Adhyaya
  5. Ayurvedic Pharmacopoeia of India
  6. A prospective, randomized double-blind, placebo-controlled study of safety and efficacy of a high-concentration full-spectrum extract of ashwagandha root in reducing stress and anxiety in adults (2012), PubMed
  7. Ayurvedic Pharmacopoeia of India
  8. NIH Office of Dietary Supplements
  9. NCCIH
Tags: Ashwagandha cortisol HPA axis research seasonal stress summer